2020 NOV 18 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx COVID-19 Daily -- New research on Telemedicine is the subject of a report. According to news reporting from Nashville, Tennessee, by NewsRx journalists, research stated, “The coronavirus disease 2019 (COVID-19) pandemic necessitated rapid changes in medical practice. Many of these changes may add value to care, creating opportunities going forward.”

Financial supporters for this research include Blank Family Foundation, Prostate Cancer Foundation, US National Cancer Institute, NIHR Research Professorship.

The news correspondents obtained a quote from the research from Vanderbilt University, “To provide an evidence-informed, expert-derived review of genitourinary cancer care moving forward following the initial COVID-19 pandemic. A collaborative narrative review was conducted using literature published through May 2020 (PubMed), which comprised three main topics: reduced in-person interactions arguing for increasing virtual and image-based care, optimisation of the delivery of care, and the effect of COVID-19 in health care facilities on decision-making by patients and their families. Patterns of care will evolve following the COVID-19 pandemic. Telemedicine, virtual care, and telemonitoring will increase and could offer broader access to multidisciplinary expertise without increasing costs. Comprehensive and integrative telehealth solutions will be necessary, and should consider patients’ mental health and access differences due to socioeconomic status. Investigations and treatments will need to maximise efficiency and minimise health care interactions. Solutions such as one stop clinics, day case surgery, hypofractionated radiotherapy, and oral or less frequent drug dosing will be preferred. The pandemic necessitated a triage of those patients whose treatment should be expedited, delayed, or avoided, and may persist with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in circulation. Patients whose demographic characteristics are at the highest risk of complications from COVID-19 may re-evaluate the benefit of intervention for less aggressive cancers. Clinical research will need to accommodate virtual care and trial participation. Research dissemination and medical education will increasingly utilise virtual platforms, limiting in-person professional engagement; ensure data dissemination; and aim to enhance patient engagement. The COVID-19 pandemic will have lasting effects on the delivery of health care. These changes offer opportunities to improve access, delivery, and the value of care for patients with genitourinary cancers but raise concerns that physicians and health administrators must consider in order to ensure equitable access to care. Patient summary: The coronavirus disease 2019 (COVID-19) pandemic has dramatically changed the care provided to many patients with genitourinary cancers.”

According to the news reporters, the research concluded: “This has necessitated a transition to telemedicine, changes in threshold or delays in many treatments, and an opportunity to reimagine patient care to maintain safety and improve value moving forward.”

This research has been peer-reviewed.

For more information on this research see: The Impact of the Covid-19 Pandemic On Genitourinary Cancer Care: Re-envisioning the Future. European Urology, 2020;78(5):731-742. European Urology can be contacted at: Elsevier, Radarweg 29, 1043 Nx Amsterdam, Netherlands. (Elsevier - www.elsevier.com; European Urology - http://www.journals.elsevier.com/european-urology/)

Our news journalists report that additional information may be obtained by contacting Christopher J. D. Wallis, Vanderbilt University, Dept. of Urology, Med Ctr, Nashville, TN 37232, United States. Additional authors for this research include James W. F. Catto, Antonio Finelli, Adam W. Glaser, John L. Gore, Stacy Loeb, Todd M. Morgan, Ted A. Skolarus, Alicia K. Morgans, Nicolas Mottet, Richard Neal, Tim O’Brien, Anobel Y. Odisho, Thomas Powles, Bernadett Szabados, Angela B. Smith, Zachary Klaassen and Daniel E. Spratt.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1016/j.eururo.2020.08.030. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

(Our reports deliver fact-based news of research and discoveries from around the world.)

Companies

Industries

Healthcare
      Healthcare Technology
            Telemedicine

Places

Subjects

Science and Technology
      Scientific Research
Health and Wellness
      Medical Conditions and Diseases
            Cancer
                  Prostate Cancer
            Infections and Infectious Diseases
                  Virology & Viral Diseases
                        Coronavirus Diseases
                              COVID-19 Novel Coronavirus
            Men's Health Issues
                  Prostate Cancer
            Urological Diseases
      Health Sciences
            Public Health
                  Infection Control and Epidemiology
                        Communicable Disease Outbreak
      Medical Specialties and Practices
            Urology
      Public Health
            Infection Control and Epidemiology
                  Communicable Disease Outbreak
Life and Society
      Philanthropy